| regulation of anagen | GO:0051884 | 1 | 0.186 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.128 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.126 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.121 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.101 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.093 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.087 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.087 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.081 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.080 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.078 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.078 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.076 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.076 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.074 | |
| cation transport | GO:0006812 | 399 | 0.072 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.071 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.070 | |
| cell maturation | GO:0048469 | 127 | 0.070 | |
| synapse organization | GO:0050808 | 125 | 0.064 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.064 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.063 | |
| organelle localization | GO:0051640 | 179 | 0.063 | |
| cell adhesion | GO:0007155 | 329 | 0.062 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.061 | |
| membrane organization | GO:0061024 | 245 | 0.061 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.060 | |
| renal outer medulla development | GO:0072054 | 2 | 0.059 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.056 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.056 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.053 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.052 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.051 | |
| chemotaxis | GO:0006935 | 247 | 0.051 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.051 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.051 | |
| oviduct development | GO:0060066 | 3 | 0.050 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.050 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.050 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.050 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.050 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.049 | |
| gastrulation | GO:0007369 | 116 | 0.049 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.048 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.048 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.048 | |
| negative regulation of fibroblast growth factor production | GO:0090272 | 2 | 0.047 | |
| mapk cascade | GO:0000165 | 281 | 0.047 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.047 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.046 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.046 | |
| aminoglycan metabolic process | GO:0006022 | 34 | 0.046 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.046 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.045 | |
| establishment of anatomical structure orientation | GO:0048560 | 1 | 0.045 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.044 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.043 | |
| calcium ion transport | GO:0006816 | 159 | 0.043 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.043 | |
| protein ubiquitination | GO:0016567 | 171 | 0.043 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.043 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.042 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.042 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.042 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.042 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.042 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.042 | |
| stem cell development | GO:0048864 | 219 | 0.042 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.041 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.041 | |
| male gonad development | GO:0008584 | 88 | 0.041 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.041 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.041 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.041 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.040 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.040 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.040 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.040 | |
| cellular homeostasis | GO:0019725 | 240 | 0.039 | |
| maintenance of cell number | GO:0098727 | 3 | 0.039 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.039 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.039 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.039 | |
| hair cycle | GO:0042633 | 90 | 0.039 | |
| steroid metabolic process | GO:0008202 | 119 | 0.039 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.039 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.038 | |
| amine metabolic process | GO:0009308 | 45 | 0.038 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.038 | |
| response to starvation | GO:0042594 | 65 | 0.037 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.037 | |
| epithelial cell development | GO:0002064 | 159 | 0.037 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.037 | |
| pole plasm assembly | GO:0007315 | 2 | 0.037 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.037 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.036 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.036 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.036 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.036 | |
| spermatogenesis | GO:0007283 | 284 | 0.036 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.036 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.036 | |
| gonad development | GO:0008406 | 141 | 0.036 | |
| digestive system development | GO:0055123 | 200 | 0.036 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.035 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.035 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.035 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.035 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.035 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.035 | |
| phagocytosis | GO:0006909 | 66 | 0.035 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.035 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.035 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.035 | |
| lung cell differentiation | GO:0060479 | 30 | 0.035 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.034 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.034 | |
| endomembrane system organization | GO:0010256 | 147 | 0.033 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.033 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.033 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.033 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.033 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.033 | |
| stem cell differentiation | GO:0048863 | 268 | 0.033 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.033 | |
| female sex differentiation | GO:0046660 | 84 | 0.033 | |
| telencephalon development | GO:0021537 | 186 | 0.033 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.032 | |
| sensory perception of sound | GO:0007605 | 97 | 0.032 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.032 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.032 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.032 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.032 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.032 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.031 | |
| male sex differentiation | GO:0046661 | 109 | 0.031 | |
| negative regulation of alcohol biosynthetic process | GO:1902931 | 4 | 0.031 | |
| endocrine system development | GO:0035270 | 98 | 0.031 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.031 | |
| hindbrain formation | GO:0021576 | 1 | 0.031 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.031 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.031 | |
| cell fate commitment | GO:0045165 | 210 | 0.031 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.031 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.031 | |
| stem cell maintenance | GO:0019827 | 130 | 0.031 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.031 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.031 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.031 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.031 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.030 | |
| spemann organizer formation | GO:0060061 | 2 | 0.030 | |
| exocytosis | GO:0006887 | 121 | 0.030 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.030 | |
| hindbrain development | GO:0030902 | 128 | 0.030 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.030 | |
| muscle tissue development | GO:0060537 | 308 | 0.030 | |
| epidermis development | GO:0008544 | 187 | 0.030 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.029 | |
| gland development | GO:0048732 | 330 | 0.029 | |
| chromatin modification | GO:0016568 | 187 | 0.029 | |
| interleukin 8 production | GO:0032637 | 4 | 0.029 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.029 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.029 | |
| renal vesicle induction | GO:0072034 | 3 | 0.029 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.029 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.029 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.029 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.028 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.028 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.028 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.028 | |
| skin development | GO:0043588 | 220 | 0.028 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.028 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.028 | |
| lung epithelium development | GO:0060428 | 37 | 0.028 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.028 | |
| respiratory system development | GO:0060541 | 190 | 0.028 | |
| female gamete generation | GO:0007292 | 74 | 0.028 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.028 | |
| microtubule based process | GO:0007017 | 236 | 0.028 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.027 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.027 | |
| foregut regionalization | GO:0060423 | 3 | 0.027 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.027 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.027 | |
| regulation of cell motility | GO:2000145 | 236 | 0.027 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.027 | |
| extracellular structure organization | GO:0043062 | 148 | 0.027 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.027 | |
| forebrain development | GO:0030900 | 302 | 0.027 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.027 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.027 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.026 | |
| stem cell proliferation | GO:0072089 | 117 | 0.026 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.026 | |
| lateral inhibition | GO:0046331 | 1 | 0.026 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.026 | |
| cytokine production | GO:0001816 | 319 | 0.026 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.026 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.026 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.026 | |
| sensory perception | GO:0007600 | 245 | 0.026 | |
| negative regulation of stem cell proliferation | GO:2000647 | 12 | 0.026 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.026 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.025 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.025 | |
| cardiac epithelial to mesenchymal transition | GO:0060317 | 18 | 0.025 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.025 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.025 | |
| hair follicle development | GO:0001942 | 85 | 0.025 | |
| blastocyst development | GO:0001824 | 80 | 0.025 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.025 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.024 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.024 | |
| cerebellum formation | GO:0021588 | 1 | 0.024 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.024 | |
| cellular response to starvation | GO:0009267 | 57 | 0.024 | |
| plasma membrane organization | GO:0007009 | 90 | 0.024 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.024 | |
| regulation of binding | GO:0051098 | 111 | 0.024 | |
| neuron projection guidance | GO:0097485 | 141 | 0.024 | |
| leukocyte migration | GO:0050900 | 124 | 0.024 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.024 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.024 | |
| gas homeostasis | GO:0033483 | 3 | 0.024 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.024 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.024 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.024 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.023 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.023 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.023 | |
| paraxial mesoderm development | GO:0048339 | 18 | 0.023 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.023 | |
| lung induction | GO:0060492 | 3 | 0.023 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.023 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.023 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.023 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.023 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.023 | |
| respiratory tube development | GO:0030323 | 167 | 0.023 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.023 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.023 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.023 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.023 | |
| heart morphogenesis | GO:0003007 | 178 | 0.023 | |
| germ cell development | GO:0007281 | 185 | 0.023 | |
| chromatin organization | GO:0006325 | 206 | 0.022 | |
| placenta development | GO:0001890 | 140 | 0.022 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.022 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.022 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.022 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.022 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.022 | |
| mesoderm development | GO:0007498 | 100 | 0.022 | |
| cerebellum development | GO:0021549 | 77 | 0.022 | |
| positive regulation of mesoderm development | GO:2000382 | 2 | 0.022 | |
| palate development | GO:0060021 | 76 | 0.022 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.022 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.022 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.022 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.022 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.022 | |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.021 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.021 | |
| tissue homeostasis | GO:0001894 | 115 | 0.021 | |
| spinal cord development | GO:0021510 | 81 | 0.021 | |
| response to acid chemical | GO:0001101 | 111 | 0.021 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.021 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.021 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.021 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.021 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.021 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.021 | |
| sensory perception of taste | GO:0050909 | 18 | 0.021 | |
| action potential | GO:0001508 | 78 | 0.021 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.021 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.021 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.021 | |
| nuclear division | GO:0000280 | 158 | 0.021 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.021 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.021 | |
| mesoderm formation | GO:0001707 | 62 | 0.021 | |
| protein processing | GO:0016485 | 163 | 0.020 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.020 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.020 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.020 | |
| cellular response to parathyroid hormone stimulus | GO:0071374 | 2 | 0.020 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.020 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.020 | |
| somite development | GO:0061053 | 81 | 0.020 | |
| cardiac chamber development | GO:0003205 | 108 | 0.020 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.020 | |
| regulation of cell differentiation involved in embryonic placenta development | GO:0060800 | 1 | 0.020 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.020 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.020 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.020 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.020 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.020 | |
| pallium development | GO:0021543 | 120 | 0.020 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.019 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.019 | |
| segmentation | GO:0035282 | 93 | 0.019 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.019 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.019 | |
| regionalization | GO:0003002 | 337 | 0.019 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.019 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.019 | |
| pancreas development | GO:0031016 | 57 | 0.019 | |
| neural tube development | GO:0021915 | 160 | 0.019 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.019 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.019 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.019 | |
| fat cell differentiation | GO:0045444 | 160 | 0.019 | |
| positive regulation of smad protein import into nucleus | GO:0060391 | 2 | 0.019 | |
| lung field specification | GO:0060424 | 3 | 0.019 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.019 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.019 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.018 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.018 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.018 | |
| loop of henle development | GO:0072070 | 10 | 0.018 | |
| protein localization to membrane | GO:0072657 | 108 | 0.018 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.018 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.018 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.018 | |
| dna metabolic process | GO:0006259 | 303 | 0.018 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.018 | |
| endocytosis | GO:0006897 | 168 | 0.018 | |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.018 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.018 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.018 | |
| intracellular protein transport | GO:0006886 | 204 | 0.018 | |
| muscle system process | GO:0003012 | 141 | 0.018 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.018 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.018 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.018 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.018 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.018 | |
| vesicle organization | GO:0016050 | 60 | 0.017 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.017 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.017 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.017 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.017 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.017 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.017 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.017 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.017 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.017 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.017 | |
| t cell proliferation | GO:0042098 | 120 | 0.017 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.017 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.017 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.017 | |
| regulation of cell migration | GO:0030334 | 219 | 0.017 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.017 | |
| spermatid differentiation | GO:0048515 | 115 | 0.017 | |
| neuromuscular process | GO:0050905 | 99 | 0.017 | |
| cell division | GO:0051301 | 120 | 0.017 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.017 | |
| skeletal system development | GO:0001501 | 356 | 0.017 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.017 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.017 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.016 | |
| lung development | GO:0030324 | 164 | 0.016 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.016 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.016 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.016 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.016 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.016 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.016 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.016 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.016 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.016 | |
| interferon gamma production | GO:0032609 | 67 | 0.016 | |
| regulation of protein localization | GO:0032880 | 231 | 0.016 | |
| metanephric capsule morphogenesis | GO:0072265 | 1 | 0.016 | |
| camera type eye development | GO:0043010 | 266 | 0.016 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.016 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.016 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.016 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.016 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.016 | |
| axonogenesis | GO:0007409 | 274 | 0.016 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.016 | |
| neuron death | GO:0070997 | 154 | 0.016 | |
| retina homeostasis | GO:0001895 | 23 | 0.016 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.016 | |
| response to parathyroid hormone | GO:0071107 | 3 | 0.016 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.016 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.016 | |
| response to amino acid | GO:0043200 | 37 | 0.016 | |
| vesicle localization | GO:0051648 | 86 | 0.016 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.016 | |
| regulation of secretion | GO:0051046 | 274 | 0.016 | |
| female gonad development | GO:0008585 | 71 | 0.016 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.016 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.016 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.016 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.016 | |
| positive regulation of growth | GO:0045927 | 104 | 0.015 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.015 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.015 | |
| tissue remodeling | GO:0048771 | 102 | 0.015 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.015 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.015 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.015 | |
| sodium ion transport | GO:0006814 | 73 | 0.015 | |
| prostate gland stromal morphogenesis | GO:0060741 | 2 | 0.015 | |
| response to histamine | GO:0034776 | 1 | 0.015 | |
| response to peptide hormone | GO:0043434 | 127 | 0.015 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.015 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.015 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.015 | |
| male gamete generation | GO:0048232 | 285 | 0.015 | |
| innate immune response | GO:0045087 | 157 | 0.015 | |
| rna interference | GO:0016246 | 2 | 0.015 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.015 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.015 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.015 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.015 | |
| cervix development | GO:0060067 | 2 | 0.015 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.015 | |
| pyramidal neuron migration | GO:0021852 | 1 | 0.015 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.015 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.015 | |
| multicellular organism growth | GO:0035264 | 161 | 0.015 | |
| establishment of planar polarity involved in neural tube closure | GO:0090177 | 15 | 0.015 | |
| renal inner medulla development | GO:0072053 | 3 | 0.015 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.014 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.014 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.014 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.014 | |
| positive regulation of meiotic cell cycle | GO:0051446 | 15 | 0.014 | |
| mesenchyme morphogenesis | GO:0072132 | 32 | 0.014 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.014 | |
| regulation of ion transport | GO:0043269 | 215 | 0.014 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.014 | |
| production of molecular mediator involved in inflammatory response | GO:0002532 | 21 | 0.014 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.014 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.014 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.014 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.014 | |
| endocrine pancreas development | GO:0031018 | 29 | 0.014 | |
| wound healing | GO:0042060 | 157 | 0.014 | |
| gtp metabolic process | GO:0046039 | 144 | 0.014 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.014 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.014 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.014 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.014 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.014 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.014 | |
| heart growth | GO:0060419 | 45 | 0.014 | |
| connective tissue development | GO:0061448 | 179 | 0.014 | |
| heart induction | GO:0003129 | 2 | 0.014 | |
| glucose homeostasis | GO:0042593 | 128 | 0.014 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.014 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.014 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.014 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.014 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.014 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.014 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.013 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.013 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.013 | |
| positive regulation of interleukin 1 secretion | GO:0050716 | 14 | 0.013 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.013 | |
| glycosaminoglycan metabolic process | GO:0030203 | 34 | 0.013 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.013 | |
| protein acylation | GO:0043543 | 64 | 0.013 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.013 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.013 | |
| histone modification | GO:0016570 | 159 | 0.013 | |
| embryonic axis specification | GO:0000578 | 30 | 0.013 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.013 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.013 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.013 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.013 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.013 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.013 | |
| organ growth | GO:0035265 | 117 | 0.013 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.013 | |
| midgut development | GO:0007494 | 4 | 0.013 | |
| mucopolysaccharide metabolic process | GO:1903510 | 25 | 0.013 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.013 | |
| skin morphogenesis | GO:0043589 | 38 | 0.012 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.012 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.012 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.012 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.012 | |
| b cell activation | GO:0042113 | 161 | 0.012 | |
| protein maturation | GO:0051604 | 176 | 0.012 | |
| organelle fission | GO:0048285 | 170 | 0.012 | |
| neural tube patterning | GO:0021532 | 43 | 0.012 | |
| actin filament organization | GO:0007015 | 113 | 0.012 | |
